PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees24
Employees24
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees24
Employees24
PDSB Key Statistics
Market cap43.77M
Market cap43.77M
Price-Earnings ratio-0.94
Price-Earnings ratio-0.94
Dividend yield—
Dividend yield—
Average volume424.39K
Average volume424.39K
High today$0.8195
High today$0.8195
Low today$0.7698
Low today$0.7698
Open price$0.7924
Open price$0.7924
Volume172.38K
Volume172.38K
52 Week high$2.20
52 Week high$2.20
52 Week low$0.703
52 Week low$0.703
Stock Snapshot
The current PDS Biotechnology(PDSB) stock price is $0.80, with a market capitalization of 43.77M. The stock trades at a price-to-earnings (P/E) ratio of -0.94.
As of 2026-01-02, PDS Biotechnology(PDSB) stock has fluctuated between $0.77 and $0.82. The current price stands at $0.80, placing the stock +3.9% above today's low and -2.4% off the high.
The PDS Biotechnology(PDSB)'s current trading volume is 172.38K, compared to an average daily volume of 424.39K.
During the past year, PDS Biotechnology(PDSB) stock moved between $0.70 at its lowest and $2.20 at its peak.
During the past year, PDS Biotechnology(PDSB) stock moved between $0.70 at its lowest and $2.20 at its peak.
People also own
Based on the portfolios of people who own PDSB. This list is generated using Robinhood data, and it’s not a recommendation.